Fomivirsen, also known by its brand name Vitravene, is a medication used in the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. This antiviral drug works by targeting specific viral genes, inhibiting the replication of the virus and helping to control the progression of the infection.

It is important to note that Fomivirsen is administered through an intravitreal injection directly into the eye, as it is specifically designed to target the CMV virus in the retina. This method of delivery allows for a more targeted and effective treatment of the infection.

As with any medication, there are potential side effects and risks associated with Fomivirsen. Some patients may experience temporary eye irritation, inflammation, or increased intraocular pressure after receiving the injection. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment.

It is crucial to follow the prescribed treatment plan and attend regular follow-up appointments with your healthcare provider while taking Fomivirsen. This will help to monitor the effectiveness of the medication and ensure that any potential side effects are addressed promptly.

Overall, Fomivirsen has been shown to be an effective treatment option for CMV retinitis in patients with AIDS. By working to inhibit the replication of the virus, this medication can help to control the progression of the infection and preserve vision in affected individuals. If you have been diagnosed with CMV retinitis, speak with your healthcare provider to see if Fomivirsen may be a suitable treatment option for you.